Locations:
Search IconSearch

Cancer

Dr. Megan Kruse
January 4, 2023/Cancer/Research

Invasive Lobular Cancer and Invasive Ductal Cancer Require Different Clinical Management

Patients with ER-positive invasive lobular cancer face worse disease-free survival and overall survival

22-CNR-3430965-CQD-Hero-650×450
December 27, 2022/Cancer/Research

Sociodemographic Disparities Impact Survival in Adolescent and Young Adults with Invasive Breast Cancer

Improving social support, greater clinical trial representation and greater provider diversity should be explored to narrow disparities in care

22-NEU-3409069-CQD-Hero-650×450
December 20, 2022/Cancer

Survival Is Associated With Subsets of T Cells in Recurrent Glioblastoma Treated With SL-701

Can T-cell immunophenotyping help inform treatment decisions?

22-CNR-3423058-CQD-Hero-650×450 Dr Moore
December 20, 2022/Cancer/Research

Stopping Hormone Therapy for Pregnancy in Patients with Hormone-Receptor Positive Breast Cancer

First prospective study looks at endocrine therapy interruption in premenopausal patients

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

breast cancer cells
December 16, 2022/Cancer/Research

Researchers Identify Risk Factors of Secondary Malignancy in Breast Cancer Survivors

Prior history of autoimmunity and solid organ transplantation significantly increases chance of myelodysplastic syndrome or acute myeloid leukemia

22-DDI-3242262 – Neuroendocrine Tumor-Kim-3-hero
December 15, 2022/Cancer

Neuroendocrine Tumors: Today’s GIs Likely Will Encounter Them

Cleveland Clinic program to streamline clinical care and research

Dr. Brian T. Hill
December 14, 2022/Cancer/Research

Precision Medicine Approach Needed to Treat Subgroups of Diffuse Large B-Cell Lymphoma

Distinct molecular features found in five subtypes of disease

Dr. Caimi
December 13, 2022/Cancer/Research

Study Provides Insights about Chemorefractory Diffuse Large B-Cell Lymphoma

Patients who relapse early after first-line chemotherapy are often, but not always, refractory to second-line chemotherapy

22-CNR-3405917-CQD-Hero-650×450 blood clot
December 12, 2022/Cancer/Research

Study Finds Biomarkers of Complications in Patients with Cancer Diagnosed with COVID-19

Elevated levels of vWF and FVIII associated with risk of blood clots, severe COVID-19 and death

BackPage 14 of 140Next

Advertisement

Ad